Evaluation of adherence to guideline-directed therapy and risk factors for exacerbation in mild asthma: a retrospective chart review

• Published in: Allergy, asthma, and clinical immunology Vol. 20; no. 1; p. 27
• Main Authors: Zerr, Beth A, Kruse, Jacklyn M, Glover, Jon J
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 28.03.2024; BioMed Central; BMC
• Subjects: Asthma; Asthma exacerbations; Bronchitis; Cardiovascular equipment; Corticosteroids; Documentation; Emergency medical care; Exacerbation; Females; Gastroesophageal reflux; Inhaled corticosteroids; Internal medicine; Medicine; Mild asthma; Patient compliance; Patients; Primary care; Risk factors; United States > US; Exacerbation; Corticosteroids; Mild asthma; GINA; Reliever medication; Asthma exacerbations; Inhaled corticosteroids; SABA; Mild persistent asthma; Asthma

A significant update was made to both the Global Initiative for Asthma (GINA) in 2019 and the National Heart Lung and Blood Institute (NHLBI) asthma guidelines in 2020 for mild asthma. These groups no longer recommend short-acting beta-agonists (SABA) as monotherapy for mild (GINA) or mild-persisten...